CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for OncoTherapy Science, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

OncoTherapy Science, Inc.
1-2, Higashida-cho, Kawasaki-ku
Phone: +81 442016429p:+81 442016429 KAWASAKI-SHI, KNG  210-0005  Japan Ticker: 45644564
Business Summary
OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HatsuoKato 79 6/1/2020 6/1/2020
President, Chief Executive Officer, Chief Scientific Officer, President of Subsidiary, Representati JaehyunPark 47 12/1/2019 6/1/2018
Director JunichiShimada 61 6/1/2022 6/1/2022
3 additional Officers and Directors records available in full report.

Business Names
Business Name
4564
Onco Therapy Science Inc.
OncoTherapy Science Inc.
OncoTherapy Science, Inc.

General Information
Number of Employees: 54 (As of 3/31/2024)
Outstanding Shares: 271,643,649 (As of 9/30/2024)
Shareholders: 38,203
Stock Exchange: TYO
Fax Number: +81 442016473


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024